Click HereClick Here
eTARGET supporting Molecular Tumour Boards
- DHP Purpose – Interpretation
- Licence – MIT /GLP 3.0
- Maturity – Multi Centre
eTARGET has overcome the challenge of integrating data from disparate sources in different organisations.
It presents a single view of patient clinical and genomic NGS data to support decision making for an MTB.
Integrates clinical and genomic data to support decision making by Molecular Tumour Boards. Developed by the Manchester Cancer Research Centre as part of the TARGET trial (Tumour chARacterisation to Guide Experimental Targeted therapy)
Integrates clinical, tumour NGS and circulating tumour DNA NGS data
eTARGET is a web solution deployed within Microsoft Azure